President Donald Trump is attempting to seize further control of funding decisions made by the National Institutes of Health. | President Donald Trump is attempting to seize further control of funding ...

China is aiming to account for at least 25% of first-in-class drugs as part of a five-year push to cement its emerging status as a hotbed for innovative R&D. | China is aiming to account for at least ...

Following Takeda’s historic approval of the first orexin agonist with its narcolepsy treatment Orzeyful, Alkermes has followed up with pioneering data that looks to take the hyped drug class out of ...

Telix has struck a deal to buy ITM Isotope Technologies Munich | Telix has struck a deal to buy ITM Isotope Technologies Munich for $1.65 billion upfront, securing an R&D pipeline led by a rival to ...

A midstage study of Cue Biopharma’s hives drug candidate has hit its primary endpoint, emboldening the biotech to move the would-be challenger to Xolair into a phase 2b/3 trial.

Eli Lilly-backed TRex Bio and hypertension-focused Retension Pharmaceuticals are the latest biotechs to set out plans to go ...

Beacon Therapeutics has found the light in a rare vision loss disease that has left larger companies in the dark. | Beacon Therapeutics has found the light in a rare vision loss disease that has left ...

After decades of hard-won progress, ALS drug development is entering a new era, building on established efficacy measures like survival and ALSFRS-R with biology-driven science that captures the full ...

Artelo Biosciences’ oral dual cannabinoid agonist showed weight loss comparable to the GLP-1 receptor agonist semaglutide in obese mice. | Artelo Biosciences’ oral dual cannabinoid agonist showed ...

New-look Novo is digging deeper into its metabolic roots with three new obesity programs purchased from New York biotech Kallyope. | New-look Novo is digging deeper into its metabolic roots with three ...

Prediction markets are opening up new ways to bet on biopharma events, from clinical trial readouts to FDA approvals. | In this episode of “The Top Line,” we explore the growing space of biopharma ...

The FDA cleared Medtronic’s LigSure RAS Maryland jaw vessel sealer-divider to be used in combination with the device maker’s Hugo robotic-assisted surgery system. The device is geared toward providing ...